Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VINCRISTINE vs VISMODEGIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VINCRISTINE vs VISMODEGIB: Safety Overview

Metric VINCRISTINE VISMODEGIB
Total FAERS Reports 72,554 8,135
Deaths Reported 14,548 864
Death Rate 20.1% 10.6%
Hospitalizations 26,911 974
Average Patient Age 41.6 yrs 69.6 yrs
% Female Patients 43.7% 39.3%
FDA Approval Date Approved Prior to Jan 1, 1982 Jan 30, 2012
Manufacturer Hospira, Inc. Genentech, Inc.
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription